Working… Menu
Trial record 45 of 422 for:    TRANEXAMIC ACID

Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03846973
Recruitment Status : Recruiting
First Posted : February 20, 2019
Last Update Posted : February 22, 2019
Information provided by (Responsible Party):
Dr. Ayman El-Menyar, Hamad Medical Corporation

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020
World Health Organization. Violence, Injuries, and Disability: Biennial 2008-2009 Report. Geneva, Switzerland: WHO; 2010.
Pre-hospital Anti-fibrinolytics for Traumatic Coagulopathy and Haemorrhage (The PATCH Study) (PATCH). Ongoing Clinical Trials. Retrieved from accessed on May 20, 2016
Electronics Medicines Compendium (2011) Cyklopron Standard Product Characteristics. [Accessed 23rd May 2016].
World Health Organisation (2011) Model Lists of Essential Medicines. 17th Ed. Accessed 23rd May 2016].